Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Christopher Patusky

Director at UNITED THERAPEUTICS Corp (UTHR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M

Reported trades

Filed Stock Type Shares Price Value Since
Apr 24SEC UTHRUNITED THERAPEUTICS Corp Sell Plan 2,9101,490 held (−66%) $569.00 $1.7M -6.3%
Apr 17SEC UTHRUNITED THERAPEUTICS Corp Sell Plan 1,0001,490 held (−40%) $578.88 $579K -7.9%
Dec 16SEC UTHRUNITED THERAPEUTICS Corp Sell 1,0001,490 held (−40%) $495.95 $496K +7.5%
  • Sell

    Director Christopher Patusky sold $1.7M of UTHR at $569.00 — cuts the stake by 66%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Christopher Patusky sold $579K of UTHR at $578.88 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Christopher Patusky sold $496K of UTHR at $495.95 — cuts the stake by 40%.